These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 2000278)
1. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Dunn MS; Shennan AT; Zayack D; Possmayer F Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278 [TBL] [Abstract][Full Text] [Related]
2. Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Dunn MS; Shennan AT; Possmayer F Pediatrics; 1990 Oct; 86(4):564-71. PubMed ID: 2216622 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091 [TBL] [Abstract][Full Text] [Related]
4. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176 [TBL] [Abstract][Full Text] [Related]
5. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML; Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872 [TBL] [Abstract][Full Text] [Related]
6. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230 [TBL] [Abstract][Full Text] [Related]
8. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109 [TBL] [Abstract][Full Text] [Related]
9. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Hoekstra RE; Jackson JC; Myers TF; Frantz ID; Stern ME; Powers WF; Maurer M; Raye JR; Carrier ST; Gunkel JH Pediatrics; 1991 Jul; 88(1):10-8. PubMed ID: 2057245 [TBL] [Abstract][Full Text] [Related]
10. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Liechty EA; Donovan E; Purohit D; Gilhooly J; Feldman B; Noguchi A; Denson SE; Sehgal SS; Gross I; Stevens D Pediatrics; 1991 Jul; 88(1):19-28. PubMed ID: 2057268 [TBL] [Abstract][Full Text] [Related]
11. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome. Ghaemi S; Mohamadymasodi M; Kelishadi R Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953 [TBL] [Abstract][Full Text] [Related]
13. Repeat surfactant therapy for postsurfactant slump. Katz LA; Klein JM J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907 [TBL] [Abstract][Full Text] [Related]
15. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants]. de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193 [TBL] [Abstract][Full Text] [Related]
16. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Kari MA; Hallman M; Eronen M; Teramo K; Virtanen M; Koivisto M; Ikonen RS Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070 [TBL] [Abstract][Full Text] [Related]
17. Surfactant replacement in neonates with early chronic lung disease. Pandit PB; Dunn MS; Kelly EN; Perlman M Pediatrics; 1995 Jun; 95(6):851-4. PubMed ID: 7761208 [TBL] [Abstract][Full Text] [Related]
19. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods. Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505 [TBL] [Abstract][Full Text] [Related]
20. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Durand M; Sardesai S; McEvoy C Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]